134
Views
11
CrossRef citations to date
0
Altmetric
Clinical features - Case Report

Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer

ORCID Icon & ORCID Icon
Pages 568-571 | Received 29 Mar 2020, Accepted 24 Apr 2020, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhigang Fu, Chunyan Wang, Wei Wei, Guangming Xiang, Li Guan, Ming Zhan, Wentian Li, Xiaogang Peng, Zheng Gong & Baoan Gao. (2022) Efficacy and safety of drug-eluting beads bronchial arterial chemoembolization versus conventional bronchial arterial chemoembolization in lung cancer patients with hemoptysis. Future Oncology 18:25, pages 2805-2815.
Read now
Hu Lin, Qin Wang, Fangfang Tian, Rui Zhang, Mi Mu, Weiguo Zhao & Pengtao Bao. (2021) Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study. Cancer Management and Research 13, pages 6239-6248.
Read now

Articles from other publishers (9)

Linqiang Lai, Fenfen Xu, Dengke Zhang, Jie Chen, Xihui Ying, Li Chen, Jiahao Wu, Jingjing Song, Weiwen Li, Jiansong Ji & Jianfei Tu. (2024) Bronchial arterial chemoembolization with Drug-Eluting beads plus sequential chemotherapy for the treatment of stage III and IV lung squamous cell carcinoma. European Journal of Radiology 175, pages 111398.
Crossref
Guocan Yu, Yanqin Shen, Liangliang Chen, Xudong Xu & Jun Yang. (2023) Drug-eluting beads bronchial arterial chemoembolization vs. conventional bronchial arterial chemoembolization in the treatment of advanced non-small cell lung cancer. Frontiers in Medicine 10.
Crossref
Haitao Liu, Yahua Li, Zongming Li, Xinwei Han & Kewei Ren. (2023) Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma. Frontiers in Pharmacology 14.
Crossref
Yu Wei Zhao, Song Liu, Hao Qin, Jin Bo Sun, Mao Su, Guang Ji Yu, Jun Zhou, Fei Gao, Ruo Yu Wang, Tong Zhao & Guang Sheng Zhao. (2023) Efficacy and safety of CalliSpheres drug-eluting beads for bronchial arterial chemoembolization for refractory non-small-cell lung cancer and its impact on quality of life: A multicenter prospective study. Frontiers in Oncology 13.
Crossref
Guanghui He, Kunning Yang, Xiaofa Zhang, Jianliang Pan, Aiqiang Han, Zhi Gao, Yuliang Li & Wujie Wang. (2023) Bronchial artery chemoembolization with drug-eluting beads versus bronchial artery infusion followed by polyvinyl alcohol particles embolization for advanced squamous cell lung cancer: A retrospective study. European Journal of Radiology 161, pages 110747.
Crossref
Xu Ma, Di Zheng, Jie Zhang, Yu Dong, Lingling Li, Bing Jie & Sen Jiang. (2022) Clinical outcomes of vinorelbine loading CalliSpheres beads in the treatment of previously treated advanced lung cancer with progressive refractory obstructive atelectasis. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Kewei Ren, Jianan Wang, Yahua Li, Zongming Li, Kunpeng Wu, Zihe Zhou, Yifan Li & Xinwei Han. (2022) The Efficacy of Drug-eluting Bead Transarterial Chemoembolization Loaded With Oxaliplatin for the Treatment of Stage III-IV Non-small-cell Lung Cancer. Academic Radiology 29:11, pages 1641-1646.
Crossref
Yonghua Bi, Bo Zhang, Jianzhuang Ren, Xinwei Han & Wenze Wu. (2022) Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study. Frontiers in Pharmacology 13.
Crossref
Yuan-Ming Li, Run-Qi Guo, Zhi-Xin Bie, Bin Li & Xiao-Guang Li. (2021) Sintilimab plus Bronchial Arterial Infusion Chemotherapy/Drug-Eluting Embolic Chemoembolization for Advanced Non–Small Cell Lung Cancer: A Preliminary Study of 10 Patients. Journal of Vascular and Interventional Radiology 32:12, pages 1679-1687.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.